unknown
Stage
1
Investors
About
Algen develops advanced CRISPR gene-modulation technology combined with AI-driven deep learning models to accelerate therapeutic drug discovery by mapping disease trajectories and RNA signaling networks.
Explore Algen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.